These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7406880)

  • 1. Effects of chymostatin and other proteinase inhibitors on protein breakdown and proteolytic activities in muscle.
    Libby P; Goldberg AL
    Biochem J; 1980 Apr; 188(1):213-20. PubMed ID: 7406880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles.
    Libby P; Goldberg AL
    Science; 1978 Feb; 199(4328):534-6. PubMed ID: 622552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo.
    Bolli R; Cannon RO; Speir E; Goldstein RE; Epstein SE
    J Am Coll Cardiol; 1983 Oct; 2(4):671-80. PubMed ID: 6350399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of protease inhibitors and decreased temperature on the degradation of different classes of proteins in cultured hepatocytes.
    Neff NT; DeMartino GN; Goldberg AL
    J Cell Physiol; 1979 Dec; 101(3):439-57. PubMed ID: 528571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of microbial proteinase inhibitors on the degradation of endogenous and internalized proteins by rat yolk sacs.
    Knowles SE; Ballard FJ; Livesey G; Williams KE
    Biochem J; 1981 Apr; 196(1):41-8. PubMed ID: 7306078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of proteinase inhibitors and amines on the lysosomal and non-lysosomal pathways of protein degradation in isolated rat hepatocytes.
    Grinde B; Seglen PO
    Biochim Biophys Acta; 1980 Sep; 632(1):73-86. PubMed ID: 7417519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy.
    Furuno K; Goodman MN; Goldberg AL
    J Biol Chem; 1990 May; 265(15):8550-7. PubMed ID: 2187867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myofibrillar proteinase, cathepsin B, and protein breakdown rates in skeletal muscle from septic rats.
    Hall-Angerås M; Hasselgren PO; Dimlich RV; Fischer JE
    Metabolism; 1991 Mar; 40(3):302-6. PubMed ID: 2000044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of protein degradation in muscle by Ca2+ or muscle injury does not involve a lysosomal mechanism.
    Furuno K; Goldberg AL
    Biochem J; 1986 Aug; 237(3):859-64. PubMed ID: 3099758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burn-induced stimulation of lysosomal enzyme activity in skeletal muscle.
    Odessey R
    Metabolism; 1986 Aug; 35(8):750-7. PubMed ID: 3526087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt.
    Gonçalves DA; Silveira WA; Lira EC; Graça FA; Paula-Gomes S; Zanon NM; Kettelhut IC; Navegantes LC
    Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E123-33. PubMed ID: 21952035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of synthetic analogues of chymostatin upon protein degradation in isolated skeletal muscle.
    Mulligan MT; Galpin IJ; Wilby AH; Beynon RJ
    Biochem J; 1985 Jul; 229(2):491-7. PubMed ID: 3899108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of muscle protein degradation by leupeptin in acutely uremic rats.
    Schaefer RM; Teschner M; Peter G; Leibold J; Kulzer P; Heidland A
    Miner Electrolyte Metab; 1988; 14(5):308-12. PubMed ID: 3173266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of epidermal transglutaminase activity by protease inhibitors.
    Kawamura H; Strickland JE; Yuspa SH
    Cancer Res; 1983 Sep; 43(9):4073-7. PubMed ID: 6135503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of chymostatin on dystrophic mice.
    Komatsu K; Matsui A; Satoh S
    Exp Neurol; 1986 Jul; 93(1):110-6. PubMed ID: 3732454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branched-chain-amino-acid-preferring peptidase activity of the lobster multicatalytic proteinase (proteasome) and the degradation of myofibrillar proteins.
    Mykles DL; Haire MF
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):285-91. PubMed ID: 7864822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of proteinase inhibitors on the cutaneous lesion of Sporothrix schenckii inoculated hairless mice.
    Lei PC; Yoshiike T; Ogawa H
    Mycopathologia; 1993 Aug; 123(2):81-5. PubMed ID: 8264771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of analogues of chymostatin on lysosomal and non-lysosomal components of protein degradation in isolated hepatocytes.
    Place GA; Chetland J; Galpin IJ; Beynon RJ
    Biochim Biophys Acta; 1987 Aug; 925(2):185-93. PubMed ID: 2887208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle.
    Taillandier D; Aurousseau E; Meynial-Denis D; Bechet D; Ferrara M; Cottin P; Ducastaing A; Bigard X; Guezennec CY; Schmid HP
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):65-72. PubMed ID: 8645234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitors reduce lysosomal acid phospholipase A1 activity in cultured rat hepatocytes.
    Schmidt M; Löffler BM; Kunze H
    Biochem Int; 1990; 20(2):337-42. PubMed ID: 2317214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.